• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis Inc (NQ: PSNL )

    2.960 +0.080 (+2.78%)
    Streaming Delayed Price Updated: 2:20 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 704,474
    Open 2.750
    Bid (Size) 2.960 (4)
    Ask (Size) 2.970 (1)
    Prev. Close 2.880
    Today's Range 2.640 - 3.080
    52wk Range 0.8906 - 4.520
    Shares Outstanding 48,518,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Breaking Down Personalis: 4 Analysts Share Their Views
    Via Benzinga

    Performance

    YTD
    +45.10%
    +45.10%
    1 Month
    +140.65%
    +140.65%
    3 Month
    +114.49%
    +114.49%
    6 Month
    +81.60%
    +81.60%
    1 Year
    +37.04%
    +37.04%

    More News

    Read More
    Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
    From Personalis, Inc.
    Via Business Wire
    4 Analysts Have This To Say About Personalis
    Via Benzinga
    Personalis: Q4 Earnings Insights
    Via Benzinga
    ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
    From Personalis, Inc.
    Via Business Wire
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Personalis Reports First Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce First Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
    Via Benzinga
    Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor
    Via Benzinga
    Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
    Via Benzinga
    Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    From Personalis, Inc.
    Via Business Wire
    Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
    From Personalis, Inc.
    Via Business Wire
    Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
    Via Benzinga
    Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
    Via Benzinga
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
    Via Benzinga
    Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.